These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23902655)

  • 1. Putting health metrics into practice: using the disability-adjusted life year for strategic decision making.
    Longfield K; Smith B; Gray R; Ngamkitpaiboon L; Vielot N
    BMC Public Health; 2013; 13 Suppl 2(Suppl 2):S2. PubMed ID: 23902655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling health impact of global health programs implemented by Population Services International.
    Yang H; Duvall S; Ratcliffe A; Jeffries D; Stevens W
    BMC Public Health; 2013; 13 Suppl 2(Suppl 2):S3. PubMed ID: 23902668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying the disability-adjusted life year to track health impact of social franchise programs in low- and middle-income countries.
    Montagu D; Ngamkitpaiboon L; Duvall S; Ratcliffe A
    BMC Public Health; 2013; 13 Suppl 2(Suppl 2):S4. PubMed ID: 23902679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9063):1436-42. PubMed ID: 9164317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Benefits of Healthcare: DALYs and QALYs - Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions.
    Augustovski F; Colantonio LD; Galante J; Bardach A; Caporale JE; Zárate V; Chuang LH; Pichon-Riviere A; Kind P
    Int J Health Policy Manag; 2018 Feb; 7(2):120-136. PubMed ID: 29524936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.
    Kim SY; Sweet S; Chang J; Goldie SJ
    BMC Infect Dis; 2011 Jun; 11():174. PubMed ID: 21679420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthopaedic trauma care in Haiti: a cost-effectiveness analysis of an innovative surgical residency program.
    Carlson LC; Slobogean GP; Pollak AN
    Value Health; 2012; 15(6):887-93. PubMed ID: 22999139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting the job done: analysis of the impact and effectiveness of the SmileTrain program in alleviating the global burden of cleft disease.
    Poenaru D
    World J Surg; 2013 Jul; 37(7):1562-70. PubMed ID: 23232819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the effectiveness of a hospital's interventions in India: impact of the choice of disability weights.
    Chatterjee S; Gosselin RA
    Bull World Health Organ; 2015 Jul; 93(7):476-82. PubMed ID: 26170505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013.
    Krishnamurthi RV; deVeber G; Feigin VL; Barker-Collo S; Fullerton H; Mackay MT; O'Callahan F; Lindsay MP; Kolk A; Lo W; Shah P; Linds A; Jones K; Parmar P; Taylor S; Norrving B; Mensah GA; Moran AE; Naghavi M; Forouzanfar MH; Nguyen G; Johnson CO; Vos T; Murray CJ; Roth GA;
    Neuroepidemiology; 2015; 45(3):177-89. PubMed ID: 26505982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan.
    Griekspoor A; Sondorp E; Vos T
    Health Policy Plan; 1999 Mar; 14(1):70-6. PubMed ID: 10351471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflections on key methodological decisions in national burden of disease assessments.
    von der Lippe E; Devleesschauwer B; Gourley M; Haagsma J; Hilderink H; Porst M; Wengler A; Wyper G; Grant I
    Arch Public Health; 2020 Dec; 78(1):137. PubMed ID: 33384020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disability-adjusted life years for severe acute malnutrition: implications of alternative model specifications.
    Puett C; Bulti A; Myatt M
    Public Health Nutr; 2019 Oct; 22(15):2729-2737. PubMed ID: 31267885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study.
    Abbas KM; van Zandvoort K; Brisson M; Jit M
    Lancet Glob Health; 2020 Apr; 8(4):e536-e544. PubMed ID: 32105613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted.
    Neumann PJ; Thorat T; Zhong Y; Anderson J; Farquhar M; Salem M; Sandberg E; Saret CJ; Wilkinson C; Cohen JT
    PLoS One; 2016; 11(12):e0168512. PubMed ID: 28005986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the value choices in DALYs influence global priority-setting?
    Arnesen T; Kapiriri L
    Health Policy; 2004 Nov; 70(2):137-49. PubMed ID: 15364144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaling up malaria intervention "packages" in Senegal: using cost effectiveness data for improving allocative efficiency and programmatic decision-making.
    Faye S; Cico A; Gueye AB; Baruwa E; Johns B; Ndiop M; Alilio M
    Malar J; 2018 Apr; 17(1):159. PubMed ID: 29636051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Burden of Malaria in Gwanda District, Zimbabwe, Using the Disability Adjusted Life Years.
    Gunda R; Chimbari MJ; Mukaratirwa S
    Int J Environ Res Public Health; 2016 Feb; 13(2):244. PubMed ID: 26907320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study.
    Jung YL; Hwang J; Yoo HS
    Global Health; 2020 Sep; 16(1):80. PubMed ID: 32912258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.
    Sepanlou SG; Parsaeian M; Krohn KJ; Afshin A; Farzadfar F; Roshandel G; Karimkhani C; Bazargan-Hejazi S; Kiadaliri AA; Ahmadieh H; Djalalinia S; Ebrahimi H; Eshrati B; Esteghamati AR; Farvid MS; Fereshtehnejad SM; Hafezi-Nejad N; Hassanvand MS; Heydarpour P; Islami F; Karimi SM; Katibeh M; Khosravi A; Khubchandani J; Mahdavi M; Pishgar F; Qorbani M; Rahimi-Movaghar V; Safi S; Sahraian MA; Shahraz S; Sheikhbahaei S; Mohammadi A; Mokdad AH; Vos T; Murray CJL; Moradi-Lakeh M; Naghavi M; Malekzadeh R
    Arch Iran Med; 2017 Jul; 20(7):403-418. PubMed ID: 28745902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.